mRNA Cancer Vaccine Shows First Success in Late-Stage Melanoma Trial
Quick Summary Drugmakers Moderna and Merck announced Wednesday that an experimental, personalized mRNA cancer vaccine slowed the return and spread of melanoma in a large, late-stage clinical trial, marking the…
